Literature DB >> 14986793

Key issues in sphincter of Oddi dysfunction.

Shyam Varadarajulu1, Robert Hawes.   

Abstract

SOD is a challenging condition that is difficult to diagnose and treat. The high failure rate of endoscopic and surgical treatment reflects the difficulties in establishing accurate diagnosis and the lack of specific objective criteria by which appropriate therapy could be determined. In general, sphincter ablation should be offered for type I patients. An initial trial of medical therapy is appropriate for type II patients with mild-to-moderate symptoms and for all type III patients. SOM is highly recommended for type II patients and is mandatory for all type III patients if sphincter ablation is contemplated. Other causes of abdominal pain such as chronic pancreatitis or functional disorders should be considered in patients not benefiting from sphincter ablation. All procedures on the sphincter should be undertaken with caution after meticulous investigation, and patient selection should be based on strict objective criteria.

Entities:  

Mesh:

Year:  2003        PMID: 14986793     DOI: 10.1016/s1052-5157(03)00074-6

Source DB:  PubMed          Journal:  Gastrointest Endosc Clin N Am        ISSN: 1052-5157


  8 in total

1.  Challenges in planning and initiating a randomized clinical study of sphincter of Oddi dysfunction.

Authors:  Peter B Cotton; Valerie Durkalski; Kyle B Orrell; Olga Brawman-Mintzer; Douglas A Drossman; C Mel Wilcox; Patrick D Mauldin; Grace H Elta; Paul R Tarnasky; Evan L Fogel; Sanjay B Jagganath; Richard A Kozarek; Martin L Freeman; Joseph Romagnuolo; Patricia R Robuck
Journal:  Gastrointest Endosc       Date:  2010-11       Impact factor: 9.427

2.  Duloxetine for the Treatment of Patients with Suspected Sphincter of Oddi Dysfunction: A Pilot Study.

Authors:  Qi Pauls; Valerie Durkalski-Mauldin; Olga Brawman-Mintzer; Chris Lawrence; Rebekah Whichard; Peter B Cotton
Journal:  Dig Dis Sci       Date:  2016-05-10       Impact factor: 3.199

3.  Can patient and pain characteristics predict manometric sphincter of Oddi dysfunction in patients with clinically suspected sphincter of Oddi dysfunction?

Authors:  Joseph Romagnuolo; Peter B Cotton; Valerie Durkalski; Qi Pauls; Olga Brawman-Mintzer; Douglas A Drossman; Patrick Mauldin; Kyle Orrell; April W Williams; Evan L Fogel; Paul R Tarnasky; Giuseppe Aliperti; Martin L Freeman; Richard A Kozarek; Priya A Jamidar; C Mel Wilcox; Jose Serrano; Grace H Elta
Journal:  Gastrointest Endosc       Date:  2014-01-25       Impact factor: 9.427

4.  Management of patients with sphincter of Oddi dysfunction based on a new classification.

Authors:  Jia-Qing Gong; Jian-Dong Ren; Fu-Zhou Tian; Rui Jiang; Li-Jun Tang; Yong Pang
Journal:  World J Gastroenterol       Date:  2011-01-21       Impact factor: 5.742

5.  Measuring episodic abdominal pain and disability in suspected sphincter of Oddi dysfunction.

Authors:  Valerie Durkalski; Walter Stewart; Paulette MacDougall; Patrick Mauldin; Joseph Romagnuolo; Olga Brawman-Minzter; Peter Cotton
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

Review 6.  Sphincter of Oddi dysfunction and pancreatitis.

Authors:  M T McLoughlin; R M S Mitchell
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

7.  How to interpret a functional or motility test - sphincter of oddi manometry.

Authors:  Young Koog Cheon
Journal:  J Neurogastroenterol Motil       Date:  2012-04-09       Impact factor: 4.924

8.  Litholytic agents as an alternative treatment modality in patients with biliary dyspepsia.

Authors:  Young Min Kim; Sung Ill Jang; Jae Hee Cho; Dong Hee Koh; Chang-Il Kwon; Tae Hoon Lee; Seok Jeong; Dong Ki Lee
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.